Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

148.18
-1.5200-1.02%
Post-market: 148.180.00000.00%18:58 EDT
Volume:1.98M
Turnover:295.47M
Market Cap:282.73B
PE:20.72
High:150.60
Open:150.01
Low:147.86
Close:149.70
52wk High:170.46
52wk Low:97.72
Shares:1.91B
Float Shares:1.82B
Volume Ratio:1.37
T/O Rate:0.11%
Dividend:4.67
Dividend Rate:3.15%
EPS(TTM):7.15
EPS(LYR):7.15
ROE:30.81%
ROA:11.14%
PB:6.13
PE(LYR):20.72

Loading ...

Novartis receives FDA approval for Cosentyx for patients aged 12 and older

TIPRANKS
·
Mar 14

Novartis AG Stock (NVS) Moved Down by 3.16% on Mar 11: Drivers Behind the Movement

TradingKey
·
Mar 11

Novartis Ag : Argus Research Raises to Buy From Hold

THOMSON REUTERS
·
Mar 11

Novartis upgraded to Buy from Hold at Argus

TIPRANKS
·
Mar 11

Market Outlook: Costco, Novartis and Devon among stock picks

Bloomberg
·
Mar 11

Novartis price target raised to CHF 110 from CHF 92 at Berenberg

TIPRANKS
·
Mar 10

Novartis (NVS) Receives a Hold from Berenberg Bank

TIPRANKS
·
Mar 09

These 8 drugs could help fight dementia - and they're already on the market

Dow Jones
·
Mar 07

BRIEF-Novo And Hims End Feud, Will Sell Obesity Drugs Together- Bloomberg News

Reuters
·
Mar 07

Novartis Shareholders Approve Dividend Raise, Share Capital Reduction

MT Newswires Live
·
Mar 06

Novartis shareholders approve all resolutions proposed by Board of Directors

TIPRANKS
·
Mar 06

Berenberg Raises Price Target on Novartis to $141 From $116, Keeps Hold Rating

MT Newswires Live
·
Mar 06

Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement

Benzinga_recent_news
·
Mar 01

Tariffs Influenced Novartis to Build Over 7 Plants in US, Trump Says

MT Newswires Live
·
Feb 28

Trump says ‘tariffs have influenced’ Novartis to build 7+ facilities

TIPRANKS
·
Feb 28

Atrium Therapeutics Begins Operations With 2 Precision Cardiology Candidates

MT Newswires Live
·
Feb 27

Novartis completes acquisition of Avidity Biosciences

TIPRANKS
·
Feb 27

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

GlobeNewswire
·
Feb 27

Novartis Says EMA Panel Recommends Remibrutinib for Chronic Spontaneous Urticaria

MT Newswires Live
·
Feb 27

Novartis receives positive CHMP opinion for remibrutinib in CSU

TIPRANKS
·
Feb 27